Drug profile · INN
imipenem
RECARBRIO
imipenem (RECARBRIO) is a bacterial penicillin-binding protein inhibitor.
EMA: approved Antiinfectives for systemic use (J01) J01DH56
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — imipenem
- Class
- Antiinfectives for systemic use (J01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
imipenem (RECARBRIO) is a bacterial penicillin-binding protein inhibitor.
Key facts
INN imipenem
Brand RECARBRIO
Mechanism Bacterial penicillin-binding protein inhibitor
Target Bacterial penicillin-binding protein
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01DH56
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is imipenem?
imipenem (RECARBRIO) is a bacterial penicillin-binding protein inhibitor.
What is the brand name for imipenem?
RECARBRIO is a marketed brand name for imipenem. Check FDA Drugs@FDA for the current US label holder and prescribing information.